Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Combining total market funds with international funds in retirement can create a diversified, tax-efficient portfolio with smoother growth.
28,507 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
When a uranium energy stock pops, investors pause to ask what changed and whether the rally can last. This guide brea...
Sunrun’s Thursday rally followed a robust first-quarter report, highlighting strong revenue growth and a surge in ene...
Space investors are watching a highly anticipated IPO-style moment as SpaceX nears price levels. This guide breaks do...
XRP trades near key resistance as bets on the CLARITY Act shift. A May 14 committee vote could reshape price paths, w...
A leading voice in personal finance questions the premise of hitting a $1 million target by age 25, urging young adul...
A sweeping study ties two decades of bat die-offs to rising crop damages, heavier local taxes, and pricier debt for r...
MicroStrategy holds a record bitcoin stash worth more than its market value, yet MSTR stock is down sharply over the ...
When a business owner handed tax duties to a trusted friend, it looked like a convenient shortcut. The result? Embezz...
A message that seems to come from the boss can trigger a chain of costly actions. This guide breaks down how these sc...
The administration says activists damaged the Reflecting Pool, while crews install fencing to curb algae and peeling ...
A glossy online romance with a powerful royal figure can feel thrilling—until the bills arrive. This article explains...